Candel Therapeutics Inc Share Price

NASDAQ: CADL

Small Cap

$4.78

-0.13

(-2.75%)

as on September 13, 2025 at 1:29 am IST

$₹

Candel Therapeutics Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$4.75
Day's Price Range
$4.93
$4.78
0.63%
Downside
3.14%
Upside
52 Week's Low
52 Week's High
$3.79
52-Week Price Range
$14.6
$4.78
20.82%
Downside
205.44%
Upside

Candel Therapeutics Inc share price movements today

Previous Close: $4.92
Open: $4.90
Volume: 1.1M
Day's Low - High: $4.75 - $4.93
52 Week Low - High: $3.79 - $14.6

Candel Therapeutics Inc Historical Returns

1 Month Return: -22.6 %
3 Month Return: -8.3 %
1 Year Return: -25.19 %
3 Year Return: + 31.07 %
5 Year Return: 0 %

Candel Therapeutics Inc Stock Fundamentals & Key Indicators

Check Candel Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$269.8M

EPS (TTM)

-0.575

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.41

Industry PE ratio

P/B Ratio

PEG Ratio

EBITDA

-34.4M

Revenue (TTM)

31.0K

Profit Margin

0.00%

Return On Equity TTM

9836100.00%

Candel Therapeutics Inc Stock Valuation

Track how Candel Therapeutics Inc P/E has moved over time to understand its valuation trends.

Candel Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 12, 2025

Industry (0.00x)

September 12, 2025

Today (-6.41x)

September 12, 2025

Highest (-0.73x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -6.41x

Candel Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Candel Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Candel Therapeutics Inc	BUY	$269.8M	NA	-6.41	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.5B	282.7%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.9B	54.04%	28.24	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.2B	2.03%	14.33	31.37%

Stock Returns calculator for Candel Therapeutics Inc Stock including INR - Dollar returns

The Candel Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Candel Therapeutics Inc investment value today

Current value as on today

₹77,870

Returns

₹22,130

(-22.13%)

Returns from Candel Therapeutics Inc Stock

₹27,245 (-27.25%)

Dollar Returns*

₹5,115 (+5.12%)

Analyst Recommendation on Candel Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Candel Therapeutics Inc. Average target price of $19.67

Candel Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Candel Therapeutics Inc.

What analysts predicted

75.7%UPSIDE

Target Price

$19.67

Current Price

$4.78

Analyzed by

7 Analysts

Target

$19.67

Candel Therapeutics Inc target price $19.67, a slight upside of 75.7% compared to current price of $4.78. According to 7 analysts rating.

Candel Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Candel Therapeutics Inc Stock has decreased by -61% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 14, 2025 to September 13, 2025

Change:-61% versus previous 30 day period

Candel Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	1	1	-	-	1	-	-
Gross Profit	0	0	0	1	0	0	0	0	0	0
Operating Income	-9	-9	-8	-10	-7	-8	-8	-8	-8	-11
EBITDA	-7	-8	-7	-10	-7	-21	-9	-13	-8	-4
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-9	-8	-11	-8	-22	-10	-14	7	-4
Income Tax Expense	0	0	0	0	0	0	-	-	-	-
Net Income	-8	-9	-8	-11	-8	-22	-10	-14	7	-4
Net Profit Margin	0.00%	0.00%	0.00%	-624.72%	-462.89%	0.00%	0.00%	-1407.30%	0.00%	0.00%

Candel Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	0	0	-
Gross Profit	-6	0	0	0	-23	0
Operating Income	-9	-13	-25	-34	-38	-33
EBITDA	-8	-13	-35	-17	-37	-52
Interest Expense	1	0	0	1	0	2
Depreciation	0	0	0	0	0	0
Income Before Tax	-8	-17	-36	-18	-37	-55
Income Tax Expense	0	4	10	-15	-	-
Net Income	-8	-22	-36	-2	-37	-55
Net Profit Margin	-6411.20%	-17739.20%	-28899.20%	-2292.80%	-122383.87%	0.00%

Candel Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-9	-8	-11	-8	-22	-10	-14	7	-4
Operating Cash Flow	-7	-8	-7	-8	-6	-6	-5	-8	-8
Investing Cash Flow	0	0	-	0	0	-	0	0	0
Financing Cash Flow	-	-	0	-1	1	1	91	-1	17
Change in Cash	-7	-8	-7	-9	-4	-4	86	-10	8

Candel Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-17	-36	-18	-37	-55
Operating Cash Flow	-9	-22	-31	-34	-27
Investing Cash Flow	38	-1	-1	0	0
Financing Cash Flow	0	71	19	0	94
Change in Cash	29	47	-12	-34	67

Global Institutional Holdings in Candel Therapeutics Inc

Funds	Holdings
FMR Inc	14.14%
Baker Bros Advisors LP	4.86%
BlackRock Inc	3.52%
Vanguard Group Inc	3.47%
Portolan Capital Management, LLC	1.76%

See all

Insights on Candel Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 79.0% return, outperforming this stock by 104.1%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 121.0% return, outperforming this stock by 89.8%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.77M → 1.0M (in $), with an average decrease of 43.7% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, CADL stock has moved down by -22.5%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 7.37M → -4.79M (in $), with an average decrease of 165.0% per quarter

About Candel Therapeutics Inc

also known as advantagene. inc., we are a massachusetts-based biotechnology company developing our proprietary immuno-oncology platforms for the treatment of solid tumors, including our gene mediated cytotoxic (gmci™) platform and our rqnestin34.5 platform. gmci™ is an "off-the-shelf" immunotherapy designed to generate a personalized, robust, and precise systemic response from the patient's own immune system against his or her cancer.

Organisation	Candel Therapeutics Inc
Headquarters	117 Kendrick Street, Needham, MA, United States, 02494
CEO	Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Candel Therapeutics Inc

Name	Title
Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.	President, CEO & Director
Dr. Seshu Tyagarajan Ph.D.	Chief Technical & Development Officer
Dr. Francesca Barone M.D., Ph.D.	Chief Scientific Officer
Mr. Charles Schoch	Senior VP, CFO, Principal Accounting Officer, Treasurer & Secretary
Ms. Ileen B. Winick	Chief People Officer
Ms. Susan Stewart J.D., L.L.M.	Chief Regulatory Officer
Dr. William Garrett Nichols M.D., M.S.	Chief Medical Officer

FAQs

What is Candel Therapeutics Inc share price today?

Candel Therapeutics Inc share price today is $4.78 as on September 13, 2025 at 1:29 am IST at the close of the market. Candel Therapeutics Inc share today touched a day high of $4.93 and a low of $4.75.

What is the 52 week high and 52 week low for Candel Therapeutics Inc share?

Candel Therapeutics Inc share touched a 52 week high of $14.6 on December 11, 2024 and a 52 week low of $3.79 on November 15, 2024. Candel Therapeutics Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $4.78,which is 67.26% down from its 52 week high and 26.29% up from its 52 week low.

What is Candel Therapeutics Inc's market capitalisation today?

Candel Therapeutics Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Candel Therapeutics Inc Stock (CADL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Candel Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Candel Therapeutics Inc Shares that will get you 0.3138 shares as per Candel Therapeutics Inc share price of $4.78 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Candel Therapeutics Inc Stock (CADL) from India?

Indian investors can start investing in Candel Therapeutics Inc (CADL) shares with as little as ₹88.25 or $1 (as of September 13, 2025 at 5:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.50 in Candel Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 13, 2025 at 5:41 am IST). Based on Candel Therapeutics Inc share’s latest price of $4.78 as on September 13, 2025 at 1:29 am IST, you will get 2.0921 shares of Candel Therapeutics Inc. Learn more about fractional shares .